Skip to main content
CRVL
NASDAQ Finance

CorVel Q2 Revenue Up 11% to $267M, EPS Up 24% to $0.67

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Insurance Stocks · Financial
Sentiment info
Positive
Importance info
7
Price
$83.23
Mkt Cap
$4.204B
52W Low
$44.83
52W High
$85.15
52W Position info
86% above low
Off High info
2.3% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

CRVL sits 86% above its 52-week low of $44.83.

Summary

CorVel reported second-quarter revenue of $267 million (up 11%) and diluted EPS of $0.67 (up 24%), with $270 million of cash, no debt, and $18.1 million of buybacks in the quarter.


Key Events · Earnings and Guidance · CRVL

  • Q2 Revenue Up 11% to $267M

    Revenue rose to $267.1 million from $239.6 million in the September 2025 quarter; six-month revenue was $527.1 million versus $474.4 million.

  • EPS Up 24%, Margin Expands

    Diluted EPS was $0.67 versus $0.54, and gross profit rose 24% to $72.3 million at a 27% gross margin, up from $58.2 million a year earlier.

  • $270M Cash, No Borrowings

    The company ended the quarter with $270 million of cash and cash equivalents and no debt; it repurchased $18.1 million of common stock during the quarter.

  • CERIS Adds Top 10 Health Plan

    CERIS implemented an additional Top 10 national health plan and formed a partnership giving it access to the Blue Cross Blue Shield market, alongside new Hospital Bill Audit and Professional Claims products.


Analysis · CRVL · Finance

CorVel delivered 11% revenue growth and a 24% increase in diluted EPS year over year, while gross margin expanded to 27% from roughly 24%. The balance sheet backs it up: $270 million of cash and no borrowings. Buybacks of $18.1 million in the quarter reduced the share count (50.5 million basic vs 51.3 million a year ago), adding support to per-share growth. The offsetting signal is insider activity: 10% owner Corstar Holdings and other insiders have sold roughly $16.3 million of stock over the past 90 days under pre-set 10b5-1 plans, so operating momentum is arriving while large holders trim.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CRVL was trading at $83.23 on NASDAQ in the Finance sector, with a market capitalization of approximately $4.2B. The 52-week trading range was $44.83 to $85.15. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CRVL - Latest Insights

CRVL
Nov 05, 2026, 4:30 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $85.91
Real-time Price: $88.28 info
Change: +$2.37 (+3%) info
Market Cap: $4.445B info
CRVL
Aug 05, 2026, 6:23 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $59.10
Real-time Price: $88.28 info
Change: +$29.18 (+49%) info
Market Cap: $4.445B info
CRVL
Aug 04, 2026, 7:37 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $59.10
Real-time Price: $88.28 info
Change: +$29.18 (+49%) info
Market Cap: $4.445B info
CRVL
Jun 26, 2026, 4:18 PM EDT
Filing Type: DEFA14A
Importance Score:
7
Price at Filing: $62.99
Real-time Price: $88.28 info
Change: +$25.29 (+40%) info
Market Cap: $4.445B info
CRVL
Jun 26, 2026, 4:16 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $62.99
Real-time Price: $88.28 info
Change: +$25.29 (+40%) info
Market Cap: $4.445B info